Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: Possible sequences of p53 alteration in stomach carcinogenesis

Virchows Archiv

Volumn 428, Issue 4-5, 1996, Pages 223-227

  Kushima, Ryoji ^a,b   Müller, Wolfram ^a   Stolte, Manfred ^c   Borchard, Franz ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Carcinogenesis; Expression; Gastric type adenoma; Intestinal type adenoma; Mucin expression; p53

Indexed keywords

PROTEIN P53;

ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INCIDENCE; MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR CELL; TUMOR SUPPRESSOR GENE;

EID: 0029834455     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00196694     Document Type: Article

References (46)

1. Baas IO, Mulder JWR, Offerhaus GJA, Vogelslein B, Hamilton SR (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 product in archival colorectal neoplasms. J Pathol 172: 5-12
2. Bara J, Loisillier F, Burtin P (1980) Antigens of gastric and intestinal mucous cells in human colonie tumours. Br J Cancer 41: 209-221
3. Borchard F, Hengels KL (1988) Sind alle drüsenbildenden Magenkarzinome intestinal differenziert? Kritische Bemerkungen zur Laurénschen Klassifikation. Verh Dtsch Ges Pathol 72: 614
4. Borchard F, Ghanei A, Koldovsky U, Hengels KJ, Bückmann FW (1990) Gastrale Differenzierung in Adenomen der Magenschleimhaut. Immunhistochemische und elektronenmikroskopische Untersuchungen. Verh Dtsch Ges Pathol 74: 528
5. Borchard F, Heilmann KL, Hermanek P, Gebbers JO, Heitz PU, Stolle M, Pfeifer U, Schaefer HE, Wiebecke B, Sehlake W (1993) Definition und klinische Bedeutung der Dysplasie im Verdauungstrakt. Pathologe 12: 50-56
6. Borchard F, Bodensieck U, Koldovsky U (1993) Entwicklung des monoklonalen Antikörpers R3C4 gegen das foveoläre Muzin M1. Verh Dtsch Ges Pathol 77: 523
7. Correa P (1988) A human model of gastric carcinogensis. Cancer Res 48: 3554-3560
8. Costa A, Marasca R, Valentinis B, Savario M, Faranda A, SiIvestrini R, Torelli G (1995) p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J Pathol 176: 45-53
9. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR (1991) Genetic basis for p53 over-expression in human breast cancer. Proc Natl Acad Sci USA 88: 5006-5010
10. Fiocca R, Villani L, Tenti P, Solcia E, Cornaggia M, Frigerio B, Capella C (1987) Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. A histopathologic, histochemical and ultrastructural study of "early" and "advanced" tumours. Pathol Res Pract 182: 308-325
11. Fiocca R, Villani L, Tenti P, Cornaggia M, Finzi G, Riva C, Capella C, Bara J, Samloff IM, Solcia E (1990) The foveolar cell component of gastric cancer. Hum Pathol 21: 260-270
12. Hanisch FG, Koldovsky U, Borchard F (1993) Monoclonal antibody 2B5 defines a truncated ο-glycan, GlcNAcβ1-3Galβ1-4GlcNAcβ1-6 (GalNAc), on mucins from deep gastric and duodenal glands as well as metaplasia and neoplasia of gastric differentiation. Cancer Res 53: 4791-4796
13. Hattori T (1985) Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. J Clin Pathol 38: 622-630
14. Hirohashi S, Sugimura T (1991) Genetic alterations in human gastric cancer. Cancer Cells 3: 49-52
15. Hong SI, Hong WS, Jang JJ, Lee DS, Cho NS, Jung ME, Kim HB, Ha GW, Park IC, Cho DS, Lee JI (1994) Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res 14: 1251-1256
16. Hurlimunn J, Saraga EP (1994) Expression of p53 protein in gastric carcinomas. Association with histologic type and prognosis. Am J Surg Pathol 18: 1247-1253
17. Hurlimann J, Chaubert P, Benhattar J (1994) p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas. Correlation between immunohistochemical and molecular biology techniques. Mod Pathol 7: 423-428
18. Kobayashi M, Watanabe H, Ajioka Y, Yoshida M, Hitomi J, Asakura H (1995) Correlation of p53 protein expression with apototic incidence in colorectal neoplasia. Virchows Arch 427: 27-32
19. Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T, Tsuneyoshi M (1994) Long term follow-up study of patients with gastric adenomas with malignant transformation. Cancer 74: 2896-2907
20. Kushima R, Hattori T (1993) Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120:103-111
21. Kushima R, Jancic S, Hattori T (1993) Association between expression of sialosyl-Tn antigen and intestinalization of gastric carcinomas. Int J Cancer 55: 904-908
22. Kushima R, Moritani S, Hattori T (1994) Over-expression of p53 protein in gastric carcinomas: relationship with development, progression and mucin-histochemical differentiation. Cancer J 7: 192-196
23. Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand [A] 64: 149-175
24. Lauwers GY, Wahl SJ, Melamed J, Rojas-Corona RR (1993) p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol 88: 1916-1919
25. Müller W, Borchard F (1996) Prognostic influence of p53 expression in gastric cancer. J Pathol 178 (in press)
26. Nakamura K, Sugano H, Takagi K (1968) Carcinoma of the stomach: its histogenesis and histological appearances. Gann 59:251-258
27. Ochiai A (1995) Gene abnormalities in cancers and premalignant lesions of the stomach (in Japanese). Pathol Clin Med 13: 107-111
28. Ranzani GN, Luinetti O, Padovan LS, Calistri D, Renault B, Burrel M, Amadori D, Fiocca R, Solcia E (1995) p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 4: 223-231
29. Sakurai S, Sano T, Nakajima T (1995) Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality. Pathol Int 45: 51-57
30. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD (1994) p53 alteration in gastric precancerous lesions. Am J Pathol 144: 511-517
31. Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM (1994) The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 25: 968-981
32. Sugano H, Nakamura K, Kato Y (1982) Pathological studies on human gastric cancer. Acta Pathol Jpn 32 [suppl 2]: 329-347
33. Sugihara H, Hattori T, Fukuda M, Fujita S (1987) Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch [A] 411: 117-127
34. Tahara E (1993) Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119: 265-272
35. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N (1990) Gastric and intestinal phenotypic expression of human stomach cancers revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 40: 494-504
36. Tatematsu M, Hasegawa R, Ogawa K, Kato T, Ichinose M, Miki K, Ito N (1992) Histogenesis of human stomach cancers based on assessment of differentiation. J Clin Gastroenterol 14 [suppl]: S1-S7
37. Todo H, Yokozaki H, Haruma K, Kajiyama G, Tahara E (1993) p53 gene mutations in gastric adenomas. Virchows Arch [B] 63: 191-195
38. Tsuda H, Hirohashi S (1994) Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer. Int J Cancer 57: 498-503
39. Uchino S, Noguchi M, Hirota T, Itabashi M, Saito T, Kobayashi M, Hirohashi S (1992) High incidence of nuclear accumulation of p53 protein in gastric cancer. Jpn J Clin Oncol 22: 225-231
40. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S (1993) p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 54: 759-764
41. Umekita Y, Kobayashi K, Seheki T, Yoshida H (1994) Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer. Jpn J Cancer Res 85: 825-830
42. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotouru Y, Yamamoto T (1993) p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68: 1134-1139
43. Watanabe H, Jass JR, Sobin LH (1990) Histological typing of oesophageal and gastric tumours. Springer. Berlin Heidelberg New York
44. Wynford-Thomas D (1992) p53 in tumour pathology: can we trust immunohistochemistry? J Pathol 166: 329-330
45. Yokozaki H, Kuniyasu H, Kitadai Y, Nishimura K, Todo H, Ayhan A, Yasui W, Ito H, Tahara E (1992) p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol 119: 67-70
46. Yonemura Y, Fushida S, Fonseca L, Tsugawa K, Ninomiya I, Yamaguchi A, Miyazaki I (1993) Overexpression of p53 protein in gastric adenoma and cancer. Int J Oncol 3: 497-501